Neurology Letters
Oral Presentations: Abstracts of the 20th Iranian Multiple Sclerosis Congress
Volume 2, Supplementary 1, January 2023
Mind and Art (ORP-01)
Volume 2, Supplementary 1, January 2023
Zahra Niknam
MS Prodrome; Is it a fact? (ORP-02)
Volume 2, Supplementary 1, January 2023
Farhad Golipoor
A narrative review on the dietary interventions in multiple sclerosis (ORP-03)
Volume 2, Supplementary 1, January 2023
Nasim Rezaeimanesh
The importance of vestibular evaluation and rehabilitation in improving the balance in MS patients (ORP-04)
Volume 2, Supplementary 1, January 2023
Saeideh Mehrkian
Physical disability assessment: EDSS calculation (ORP-05)
Volume 2, Supplementary 1, January 2023
Zahra Ebadi
Horizons of MS therapy: during 30 years (ORP-06)
Volume 2, Supplementary 1, January 2023
Seyed Massood Nabavi
Women and Multiple Sclerosis (ORP-07)
Volume 2, Supplementary 1, January 2023
Behnaz Sedighi
Clinical Outcome and Volumetric MRI Assessment of Brain and Cervical Spinal Cord Area in Secondary Progressive Multiple Sclerosis Patients Treated with Rituximab: one-year follow-up (ORP-08)
Volume 2, Supplementary 1, January 2023
Yousef Mokary; Mohammad Yazdan Panah; Fereshteh Ashtari; Maryam Ahmadi
The role of Artificial Intelligence in cognitive impairment assessment by MRI in people with MS (Iranian Research) (ORP-09)
Volume 2, Supplementary 1, January 2023
Vida Niakosari; Sana Hashemi; Ahmad Ali Abin; Maryam Poursadeghfard
Definition and treatment of the multiple sclerosis relapse (ORP-10)
Volume 2, Supplementary 1, January 2023
Maryam Poursadeghfard
What should we do to reduce the complications of Deep brain stimulation in Parkinson's disease?
Volume 1, Issue 1, June 2022, Pages 1-11
Fardin Nabizadeh
Review Current and Emerging Treatment Options for Alzheimer's Disease
Volume 2, Issue 1, April 2023, Pages 1-5
Dimple Kumar Vats; Nistara Biswas; Preethi Pandian; Anupam Kamalakannan
Quantitative Electroencephalography Findings in Treatment-resistant and Responsive Patients with Idiopathic Generalized Tonic-Clonic Epilepsy
Volume 2, Issue 1, April 2023, Pages 6-12
Sheida Shaafi; Seyede Maryam Nasibi; Gholamreza Chalabianloo; Seyed Aria Nejadghaderi
Biomaterials in The Treatment of Amyotrophic Lateral Sclerosis
Volume 1, Issue 1, June 2022, Pages 12-16
Fardin Nabizadeh
Guillain-Barré syndrome in remission of Ulcerative colitis: a case report
Volume 2, Issue 1, April 2023, Pages 13-15
Maedeh Khodkam; Delaram Panahi
Regional cerebral blood flow and brain atrophy in mild cognitive impairment and Alzheimer's disease
Volume 2, Issue 1, April 2023, Pages 16-24
Fardin Nabizadeh; Mohammad Balabandian; Mohammad Reza Rostami; Soraya Mehrabi; Mohsen Sedighi
Neuroimmunoactive biomaterial design
Volume 1, Issue 1, June 2022, Pages 17-18
Maedeh Khodkam
Neuroinflammation and Neurodegenerative disease
Volume 1, Issue 1, June 2022, Pages 19-20
Maedeh Khodkam
Diffusion tensor imaging (DTI) and plasma p-tau 181 in Alzheimer’s disease
Volume 1, Issue 1, June 2022, Pages 21-27
Fardin Nabizadeh; Seyed Behnamedin Jameie
The Interplay Between the Gut Microbiome and Neurological Disorders: Exploring the Gut-Brain Axis
Volume 2, Issue 1, April 2023, Pages 25-29
Sen Pang; Jing Wen-Yi; Wu Zi
Helicobacter Pylori specific antibodies among multiple sclerosis patients
Volume 1, Issue 1, June 2022, Pages 28-31
Seyed-Amirabbas Ahadiat; Seyed-Ali Masoud; Mohammad sadegh khorshidi; Zeinab Hosseinian; Alireza Namvari
Personalized Treatment for Multiple Sclerosis: The Role of Precision Medicine
Volume 2, Issue 1, April 2023, Pages 30-34
Lokesh Pathak
The outcomes of physical activity and health education on cognition level in sedentary seniors
Volume 1, Issue 1, June 2022, Pages 32-33
Kimia Rasouli; Aref Hoseini
Acute relapse of Multiple Sclerosis (MS) in an adolescent patient after Tuberculin skin test (TST): a case report
Volume 1, Issue 1, June 2022, Pages 34-36
Kasra Pirahesh; Aria Motamedi-Jahromi
)